Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolf, P. A.
Right arrow Articles by Kannel, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolf, P. A.
Right arrow Articles by Kannel, W. B.
NEUROLOGY 1978;28:973
© 1978 American Academy of Neurology

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke

The fiamingham Study
Philip A. Wolf, M.D, Thomas R. Dawber, M.D., M.P.H., H. Emerson Thomas, Jr., M.D. and William B. Kannel, M.D., M.P.H.

Department of Neurology (Dr. Wolf); and the Section on Preventive Medicine of the Division of Medicine (Drs. Dawber and Thomas), Boston University School of Medicine, Boston, Massachusetts; and the Heart Disease Epidemiology Study (Dr. Kannel), National Heart and Lung Institute, Framingham, Massachusetts.

Chronic atrial fibrillation (AF) as a precursor of stroke was assessed over 24 years of follow-up of the general population sample at Framingham, Massachusetts. Persons with chronic established AF, with or without rheumatic heart disease (RHD), are at greatly increased risk of stroke, and the stroke is probably due to embolism. Chronic AF in the absence of RHD is associated with more than a fivefold increase in stroke incidence, while AF with RHD has a 17-fold increase. Stroke occurrence increased as duration of AF increased, with no evidence of a particularly vulnerable period. Chronic idiopathic AF is an important precursor of cerebral embolism. Controlled trials of anticoagulants or antiarrhythmic agents in persons with chronic AF may demonstrate if strokes can be prevented in this highly susceptible group.

Reprint requests should be addressed to Dr. Wolf, Department of Neurology, Boston University School of Medicine, 80 East Concord Street, Boston, MA 02118.

Presented in part at the twenty-eighth annual meeting of the American Academy of Neurology, April 29, 1976, Toronto, Canada.

Supported in part by Research Grant NS 09695-05 from the National Institutes of Health.

Accepted for publication September 12, 1977.




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
E. Agabiti Rosei and M. Salvetti
Dronedarone: an emerging therapy for atrial fibrillation
Therapeutic Advances in Cardiovascular Disease, June 1, 2010; 4(3): 155 - 164.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. Chikwe, J. Raikhelkar, F. Filsoufi, and A. Fischer
Current Concepts in Ablation of Atrial Fibrillation
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2009; 13(4): 215 - 224.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. O. von Oppell, N. Masani, P. O'Callaghan, R. Wheeler, G. Dimitrakakis, and S. Schiffelers
Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 641 - 650.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. J. Benjamin, P.-S. Chen, D. E. Bild, A. M. Mascette, C. M. Albert, A. Alonso, H. Calkins, S. J. Connolly, A. B. Curtis, D. Darbar, et al.
Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
Circulation, February 3, 2009; 119(4): 606 - 618.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst
CHAPTER 29 Atrial Fibrillation
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. John, M. K. Stiles, P. Kuklik, S. T. Chandy, G. D. Young, L. Mackenzie, L. Szumowski, G. Joseph, J. Jose, S. G. Worthley, et al.
Electrical remodelling of the left and right atria due to rheumatic mitral stenosis
Eur. Heart J., September 2, 2008; 29(18): 2234 - 2243.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Meiltz, M. Zimmermann, P. Urban, A. Bloch, and on behalf of the Association of Cardiologists of t
Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world
Europace, June 1, 2008; 10(6): 674 - 680.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Ringborg, R. Nieuwlaat, P. Lindgren, B. Jonsson, D. Fidan, A. P. Maggioni, J. Lopez-Sendon, J. Stepinska, D. V. Cokkinos, and H. J.G.M. Crijns
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation
Europace, April 1, 2008; 10(4): 403 - 411.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. E. Cohn, I. D. Gregoric, B. Radovancevic, R. K. Wolf, and O.H. Frazier
Atrial Fibrillation After Cardiac Transplantation: Experience in 498 Consecutive Cases
Ann. Thorac. Surg., January 1, 2008; 85(1): 56 - 58.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Ferro, L. Loffredo, L. Polimeni, F. Fimognari, P. Villari, P. Pignatelli, V. Fuster, and F. Violi
Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2763 - 2768.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. Nieuwlaat, L. W. Eurlings, A. Capucci, and H. J.G.M. Crijns
Atrial fibrillation in the 'real world': undecided issues
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I122 - I128.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Zierer, S. J. Melby, R. K. Voeller, T. J. Guthrie, A. S. Al-Dadah, B. F. Meyers, M. K. Pasque, G. A. Ewald, M. R. Moon, and N. Moazami
Significance of Neurologic Complications in the Modern Era of Cardiac Transplantation
Ann. Thorac. Surg., May 1, 2007; 83(5): 1684 - 1690.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Miyasaka, M. E. Barnes, K. R. Bailey, S. S. Cha, B. J. Gersh, J. B. Seward, and T. S.M. Tsang
Mortality Trends in Patients Diagnosed With First Atrial Fibrillation: A 21-Year Community-Based Study
J. Am. Coll. Cardiol., March 6, 2007; 49(9): 986 - 992.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
S. Topaloglu, A. Boyaci, S. Ayaz, S. Yilmaz, O. Yanik, O. Ozdemir, M. Soylu, A. D. Demir, D. Aras, H. L. Kisacik, et al.
Coagulation, Fibrinolytic System Activation and Endothelial Dysfunction in Patients With Mitral Stenosis and Sinus Rhythm
Angiology, February 1, 2007; 58(1): 85 - 91.
[Abstract] [PDF]


Home page
StrokeHome page
M. Paciaroni, G. Agnelli, S. Micheli, and V. Caso
Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials
Stroke, February 1, 2007; 38(2): 423 - 430.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Nieuwlaat, A. Capucci, G. Y.H. Lip, S. B. Olsson, M. H. Prins, F. H. Nieman, J. Lopez-Sendon, P. E. Vardas, E. Aliot, M. Santini, et al.
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
Eur. Heart J., December 2, 2006; 27(24): 3018 - 3026.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. W.W. Wong and K.-H. Mak
Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes
Ann. Thorac. Surg., November 1, 2006; 82(5): 1938 - 1947.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): 700 - 752.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030.
[Full Text] [PDF]


Home page
Eur Heart JHome page
L. Friberg, N. Hammar, M. Ringh, H. Pettersson, and M. Rosenqvist
Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
Eur. Heart J., August 2, 2006; 27(16): 1954 - 1964.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
N. Turgut, O. Akdemir, B. Turgut, M. Demir, G. Ekuklu, O. Vural, G. Ozbay, and U. Utku
Hypercoagulopathy in Stroke Patients with Nonvalvular Atrial Fibrillation: Hematologic and Cardiologic Investigations
Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 15 - 20.
[Abstract] [PDF]


Home page
Eur Heart JHome page
R. Nieuwlaat, A. Capucci, A. J. Camm, S. B. Olsson, D. Andresen, D. W. Davies, S. Cobbe, G. Breithardt, J.-Y. Le Heuzey, M. H. Prins, et al.
Atrial fibrillation management: a prospective survey in ESC Member Countries: The Euro Heart Survey on Atrial Fibrillation
Eur. Heart J., November 2, 2005; 26(22): 2422 - 2434.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, J. B. Seward, K. R. Bailey, T. Iwasaka, and T. S.M. Tsang
Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000: Report of a Community-Based Study
Stroke, November 1, 2005; 36(11): 2362 - 2366.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Wani, E. Nga, and R. Navaratnasingham
Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?
BMJ, August 20, 2005; 331(7514): 439 - 442.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
R Katira, A Chauhan, and R S More
Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation
Postgrad. Med. J., June 1, 2005; 81(956): 370 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Kimura, K Minematsu, T Yamaguchi, and for the Japan Multicenter Stroke Investigators' Co
Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 679 - 683.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
P. M.W. Bath, L. Zhao, and S. Heptinstall
Current status of stroke prevention in patients with atrial fibrillation
Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C12 - C18.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. O'Donnell, G. Agnelli, and J. I. Weitz
Emerging therapies for stroke prevention in atrial fibrillation
Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C19 - C27.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. A. Marshall, A. R. Levy, H. Vidaillet, E. Fenwick, A. Slee, G. Blackhouse, H. L. Greene, D. G. Wyse, G. Nichol, B. J. O'Brien, et al.
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
Ann Intern Med, November 2, 2004; 141(9): 653 - 661.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
S. L Jackson, G. M Peterson, and J. H Vial
A Community-Based Educational Intervention to Improve Antithrombotic Drug Use in Atrial Fibrillation
Ann. Pharmacother., November 1, 2004; 38(11): 1794 - 1799.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Nakajima, J. Kobayashi, K. Bando, Y. Yasumura, S. Nakatani, K. Kimura, K. Niwaya, O. Tagusari, and S. Kitamura
Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: The necessity of the maze procedure
Ann. Thorac. Surg., September 1, 2004; 78(3): 800 - 805.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
W. E. Dager
Ximelagatran: A New Antithrombotic Option in Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 151 - 162.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
S. G. Rockson and G. W. Albers
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 929 - 935.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. F. Elias, L. M. Sullivan, R. B. D'Agostino, P. K. Elias, A. Beiser, R. Au, S. Seshadri, C. DeCarli, and P. A. Wolf
Framingham Stroke Risk Profile and Lowered Cognitive Performance
Stroke, February 1, 2004; 35(2): 404 - 409.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass
Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
Ann Intern Med, December 16, 2003; 139(12): 1018 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
R. R Kasliwal, S. Mukesh, G. Manohar, N. Aggarwal, and A. Bhatia
Pharmacotherapy of Atrial Fibrillation
Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 364 - 374.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. J. Wang, J. M. Massaro, D. Levy, R. S. Vasan, P. A. Wolf, R. B. D'Agostino, M. G. Larson, W. B. Kannel, and E. J. Benjamin
A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community: The Framingham Heart Study
JAMA, August 27, 2003; 290(8): 1049 - 1056.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. L. Waldo
Stroke Prevention in Atrial Fibrillation
JAMA, August 27, 2003; 290(8): 1093 - 1095.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. Touboul, J. Brugada, A. Capucci, H. J.G.M. Crijns, N. Edvardsson, and S. H. Hohnloser
Dronedarone for prevention of atrial fibrillation: A dose-ranging study
Eur. Heart J., August 2, 2003; 24(16): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. S.G. Conway, L. A. Pearce, B. S.P. Chin, R. G. Hart, and G. Y.H. Lip
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
Circulation, July 1, 2003; 107(25): 3141 - 3145.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. J Boos, R. S More, and J. Carlsson
Persistent atrial fibrillation: rate control or rhythm control
BMJ, June 25, 2003; 326(7404): 1411 - 1412.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Manasse, P.G. Colombo, A. Barbone, P. Braidotti, G. Bulfamante, M. Roincalli, and R. Gallotti
Clinical histopathology and ultrastructural analysis of myocardium following microwave energy ablation
Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. S.G. Conway, J. Heeringa, D. A.M. Van Der Kuip, B. S.P. Chin, A. Hofman, J. C.M. Witteman, and G. Y.H. Lip
Atrial Fibrillation and the Prothrombotic State in the Elderly: The Rotterdam Study
Stroke, February 1, 2003; 34(2): 413 - 417.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. W. Lee, N. H. Park, S. J. Choo, M. S. Jo, H. Song, and M. G. Song
Surgical outcome of the maze procedure for atrial fibrillation in mitral valve disease: rheumatic versus degenerative
Ann. Thorac. Surg., January 1, 2003; 75(1): 57 - 61.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Bonanomi, M. A. Zenati, and D. Schwartzman
Left atrial appendectomy and maze
J. Am. Coll. Cardiol., January 1, 2003; 41(1): 170 - 170.
[Full Text] [PDF]


Home page
NEJMHome page
The Atrial Fibrillation Follow-up Investigation of
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
N. Engl. J. Med., December 5, 2002; 347(23): 1825 - 1833.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. M. Prasad, H. S. Maniar, R. B. Schuessler, and R. J. Damiano Jr
Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart
J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 708 - 713.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Raj and D.G. Wyse
Rhythm control for paroxysmal atrial fibrillation after AV junction ablation: is it worth the effort?
Eur. Heart J., June 1, 2002; 23(11): 845 - 848.
[Full Text] [PDF]


Home page
HeartHome page
M Nakamura, H Endo, M Nasu, N Arakawa, T Segawa, and K Hiramori
Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population
Heart, February 1, 2002; 87(2): 131 - 135.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Maron, I. Olivotto, P. Bellone, M. R. Conte, F. Cecchi, B. P. Flygenring, S. A. Casey, T. E. Gohman, S. Bongioanni, and P. Spirito
Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 301 - 307.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. O. von Oppell, T. Rauch, G. Hindricks, H. Kottkamp, and F. Mohr
Effectiveness of two radiofrequency ablation systems in atrial tissue
Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 956 - 960.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Circulation, October 23, 2001; 104(17): 2118 - 2150.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923.
[PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1231 - 1265.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F.L Li-Saw-Hee, A.D Blann, D Gurney, and G.Y.H Lip
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function
Eur. Heart J., September 2, 2001; 22(18): 1741 - 1747.
[Abstract] [PDF]


Home page
Eur Heart JHome page
G Corrado, A Sgalambro, A Mantero, F Gentile, M Gasparini, R Bufalino, A Morabito, G Trocino, R Schiavina, S Mandorla, et al.
Thromboembolic risk in atrial flutter. The FLASIEC (FLutterAtrialeSocietaIaliana diEcografiaCardiovascolare) multicentre study
Eur. Heart J., June 2, 2001; 22(12): 1042 - 1051.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. T. Sie, W. P. Beukema, A. R. Ramdat Misier, A. Elvan, J. J. Ennema, and H. J.J. Wellens
The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery
Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 443 - 447.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
N. R Grubb and S. Furniss
Science, medicine, and the future: Radiofrequency ablation for atrial fibrillation
BMJ, March 31, 2001; 322(7289): 777 - 780.
[Full Text]


Home page
J Am Coll CardiolHome page
A. L. Klein, R. D. Murray, and R. A. Grimm
Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 691 - 704.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Chugh, J. L. Blackshear, W.-K. Shen, S. C. Hammill, and B. J. Gersh
Epidemiology and natural history of atrial fibrillation: clinical implications
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 371 - 378.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. Frost, G. Engholm, S. Johnsen, H. Moller, E. W. Henneberg, and S. Husted
Incident Thromboembolism in the Aorta and the Renal, Mesenteric, Pelvic, and Extremity Arteries After Discharge From the Hospital With a Diagnosis of Atrial Fibrillation
Arch Intern Med, January 22, 2001; 161(2): 272 - 276.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
F. Diet and E. Erdmann
Thromboembolism in heart failure: who should be treated?
Eur J Heart Fail, December 1, 2000; 2(4): 355 - 363.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
W. D. Johnson, A.K. Ganjoo, C. D. Stone, R. C. Srivyas, and M. Howard
The left atrial appendage: our most lethal human attachment! Surgical implications
Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 718 - 722.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F.-E. de Leeuw, J. C. de Groot, M. Oudkerk, J. A. Kors, A. Hofman, J. van Gijn, and M. M. B. Breteler
Atrial fibrillation and the risk of cerebral white matter lesions
Neurology, May 9, 2000; 54(9): 1795 - 1801.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. J. M. Barnett, R. W. Gunton, M. Eliasziw, L. Fleming, B. Sharpe, P. Gates, and H. Meldrum
Causes and Severity of Ischemic Stroke in Patients With Internal Carotid Artery Stenosis
JAMA, March 15, 2000; 283(11): 1429 - 1436.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Pollick
Left Atrial Appendage Myopathy : The Importance of Serial Transesophageal Assessment in Atrial Fibrillation
Chest, February 1, 2000; 117(2): 297 - 298.
[Full Text] [PDF]


Home page
ChestHome page
L.-M. Tsai, T.-H. Chao, and J.-H. Chen
Association of Follow-up Change of Left Atrial Appendage Blood Flow Velocity With Spontaneous Echo Contrast in Nonrheumatic Atrial Fibrillation
Chest, February 1, 2000; 117(2): 309 - 313.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. G. Hart and J. L. Halperin
Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
Ann Intern Med, November 2, 1999; 131(9): 688 - 695.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N M Al-Saady, O A Obel, and A J Camm
Left atrial appendage: structure, function, and role in thromboembolism
Heart, November 1, 1999; 82(5): 547 - 554.
[Abstract] [Full Text]


Home page
HeartHome page
D Deplanque, F Corea, C Arquizan, L Parnetti, J L Mas, V Gallai, D Leys, and the SAFE I Study Investigators
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand?
Heart, November 1, 1999; 82(5): 563 - 569.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
R. F. Bosch, X. Zeng, J. B. Grammer, K. Popovic, C. Mewis, and V. Kuhlkamp
Ionic mechanisms of electrical remodeling in human atrial fibrillation
Cardiovasc Res, October 1, 1999; 44(1): 121 - 131.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
J. J. Caro, K. M. Flegel, M.-E. Orejuela, H. E. Kelley, J. L. Speckman, and K. Migliaccio-Walle
Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice
Can. Med. Assoc. J., September 1, 1999; 161(5): 493 - 497.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. J. Connolly
Preventing stroke in atrial fibrillation: Why are so many eligible patients not receiving anticoagulant therapy?
Can. Med. Assoc. J., September 1, 1999; 161(5): 533 - 534.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
S. L. Kopecky, B. J. Gersh, M. D. McGoon, C.-P. Chu, D. M. Ilstrup, J. H. Chesebro, and J. P. Whisnant
Lone Atrial Fibrillation in Elderly Persons: A Marker for Cardiovascular Risk
Arch Intern Med, May 24, 1999; 159(10): 1118 - 1122.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. G. Davila-Roman, S. F. Murphy, N. J. Nickerson, N. T. Kouchoukos, K. B. Schechtman, and B. Barzilai
Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1308 - 1316.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. B. Gorelick, R. L. Sacco, D. B. Smith, M. Alberts, L. Mustone-Alexander, D. Rader, J. L. Ross, E. Raps, M. N. Ozer, L. M. Brass, et al.
Prevention of a First Stroke: A Review of Guidelines and a Multidisciplinary Consensus Statement From the National Stroke Association
JAMA, March 24, 1999; 281(12): 1112 - 1120.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
X.-H. Fang, R. A. Kronmal, S.-C. Li, W.T. Longstreth Jr, X.-M. Cheng, W.-Z. Wang, S. Wu, X.-L. Du, and D. Siscovick
Prevention of Stroke in Urban China : A Community-Based Intervention Trial
Stroke, March 1, 1999; 30(3): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Izumoto, K. Kawazoe, H. Kitahara, and J. Kamata
Operative results after the Cox/maze procedure combined with a mitral valve operation
Ann. Thorac. Surg., September 1, 1998; 66(3): 800 - 804.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Kilander, B. Andren, H. Nyman, L. Lind, M. Boberg, and H. Lithell
Atrial Fibrillation Is an Independent Determinant of Low Cognitive Function : A Cross-Sectional Study in Elderly Men
Stroke, September 1, 1998; 29(9): 1816 - 1820.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. S. Cooper, V. J. Plumb, A. E. Epstein, G. N. Kay, and R. E. Ideker
Marked Reduction in Internal Atrial Defibrillation Thresholds With Dual-Current Pathways and Sequential Shocks in Humans
Circulation, June 30, 1998; 97(25): 2527 - 2535.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Gray and J. Jalife
Effects of Atrial Defibrillation Shocks on the Ventricles in Isolated Sheep Hearts
Circulation, April 28, 1998; 97(16): 1613 - 1622.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. W. Mahaffey, C. B. Granger, M. A. Sloan, T. D. Thompson, J. M. Gore, W. D. Weaver, H. D. White, M. L. Simoons, G. I. Barbash, E. J. Topol, et al.
Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis : Results From GUSTO-I
Circulation, March 3, 1998; 97(8): 757 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. M Oppenheimer and J. Lima
Neurology and the heart
J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 289 - 297.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
P. A. Wolf, J. B. Mitchell, C. S. Baker, W. B. Kannel, and R. B. D'Agostino
Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs
Arch Intern Med, February 9, 1998; 158(3): 229 - 234.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. J. Koudstaal and A. Koudstaal
Stroke Prevention in Patients With Atrial Fibrillation: What Have We Learned?
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(1): 85 - 89.
[PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh and B. Lopez
Atrial Fibrillation: Defining Some Unanswered Questions
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 195 - 199.
[PDF]


Home page
StrokeHome page
V. L. Feigin, D. O. Wiebers, Y. P. Nikitin, W. M. O'Fallon, and J. P. Whisnant
Risk Factors for Ischemic Stroke in a Russian Community : A Population-Based Case-Control Study
Stroke, January 1, 1998; 29(1): 34 - 39.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. M. Brass, H. M. Krumholz, J. M. Scinto, and M. Radford
Warfarin Use Among Patients With Atrial Fibrillation
Stroke, December 1, 1997; 28(12): 2382 - 2389.
[Abstract] [Full Text]


Home page
CirculationHome page
R. A. S. Cooper, W. M. Smith, and R. E. Ideker
Internal Cardioversion of Atrial Fibrillation : Marked Reduction in Defibrillation Threshold With Dual Current Pathways
Circulation, October 21, 1997; 96(8): 2693 - 2700.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. F. Obadia, M. E. Farra, O. H. Bastien, M. Lievre, Y. Martelloni, and J. F. Chassignolle
OUTCOME OF ATRIAL FIBRILLATION AFTER MITRAL VALVE REPAIR
J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 179 - 185.
[Abstract] [Full Text]



pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy